Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Addiction. 2020 Mar;115(3):493-504. doi: 10.1111/add.14867. Epub 2019 Dec 21.
To examine how the risks of incident opioid use disorder (OUD), non-fatal and fatal overdose have changed over time among opioid-naive individuals receiving an initial opioid prescription.
Retrospective, longitudinal study using the Massachusetts Chapter 55 data set, which linked multiple administrative data sets to study the opioid epidemic. We identified the cumulative incidence of OUD, non-fatal and fatal overdose among the opioid-naive initiating opioid treatment in Massachusetts from 2011 to 2014 and estimated rates of these outcomes at 6 months and at 1, 2, 3 and 4 years to 2015. We used Cox regression to examine the association between characteristics of the initial prescription and risk of these outcomes.
Massachusetts, USA.
Massachusetts residents aged ≥ 11 years in 2011-15 who were opioid-naive (no opioid prescriptions or evidence of OUD in the 6 months prior to the index prescription) (n = 2 154 426). The mean age was 49.1 years, 55.3% were female and 47.3% had commercial insurance.
Opioid prescriptions were identified in the Prescription Monitoring Program (PMP) database, as were the characteristics of the initial prescription database. The outcomes of OUD and non-fatal overdose were identified from claims in the All Payer Claims Database (APCD) and hospital encounters in the acute hospital case mix files. Fatal overdoses were identified using Registry of Vital Records and Statistics (RVRS) death certificates and the Office of the Chief Medical Examiner (OCME) circumstances of death and toxicology reports.
Among opioid-naive individuals receiving an initial opioid prescription, the risk of incident OUD appears to have declined between 2011 and 2014, while rates of overdose were largely unchanged. For example, the 1-year OUD rate was 1.18% in 2011, 1.11% in 2012, 1.26% in 2013 and 0.94% in 2014. Longer therapy duration was associated with higher risk of OUD [hazard ratio (HR) = 2.24, 95% confidence interval (CI) = 2.19-2.29 for duration of 3 or more months], non-fatal (HR = 1.67, 95% CI = 1.53-1.82) and fatal opioid overdose (HR = 2.24, 95% CI = 1.91-2.61). Concurrent benzodiazepine treatment was also associated with higher risk of OUD (HR = 1.14, 95% CI = 1.12-1.17), non-fatal (HR = 1.20, 95% CI = 1.10-1.30) and fatal overdose (HR = 1.86, 95% CI = 1.61-2.16).
Among opioid-naive individuals in Massachusetts receiving an initial opioid prescription, the risk of incident opioid use disorder appears to have declined between 2011 and 2014, while rates of overdose were largely unchanged. Longer therapy duration and concurrent benzodiazepines were associated with higher rates of opioid use disorder and opioid overdose.
研究在马萨诸塞州接受初始阿片类药物处方的阿片类药物初治个体中,阿片类药物使用障碍(OUD)、非致命和致命过量的风险随时间变化的情况。
使用马萨诸塞州第 55 章数据集中的回顾性、纵向研究,该数据集将多个行政数据集联系起来研究阿片类药物流行情况。我们确定了马萨诸塞州 2011 年至 2014 年期间阿片类药物初治开始接受阿片类药物治疗的个体中 OUD、非致命和致命过量的累积发生率,并估计了这些结果在 6 个月和 1、2、3 和 4 年(截至 2015 年)的发生率。我们使用 Cox 回归分析了初始处方特征与这些结果之间的关系。
美国马萨诸塞州。
2011-15 年马萨诸塞州年龄≥11 岁的阿片类药物初治(6 个月前无阿片类药物处方或 OUD 证据)(n=2154426)。平均年龄为 49.1 岁,55.3%为女性,47.3%有商业保险。
处方监测计划(PMP)数据库中确定了阿片类药物处方,初始处方数据库中也确定了处方的特征。从所有支付者索赔数据库(APCD)中的索赔和急性医院病例组合文件中的医院就诊中确定了 OUD 和非致命性过量的结果。通过登记处的死亡证明和统计处(RVRS)、首席法医办公室(OCME)的死亡情况和毒理学报告确定了致命性过量。
在接受初始阿片类药物处方的阿片类药物初治个体中,OUD 的发病风险似乎在 2011 年至 2014 年间有所下降,而过量的发生率基本保持不变。例如,2011 年的 1 年 OUD 发生率为 1.18%,2012 年为 1.11%,2013 年为 1.26%,2014 年为 0.94%。较长的治疗时间与 OUD 的风险增加相关(风险比[HR]为 2.24,95%置信区间[CI]为 2.19-2.29)、非致命(HR 为 1.67,95%CI 为 1.53-1.82)和致命阿片类药物过量(HR 为 2.24,95%CI 为 1.91-2.61)。同时使用苯二氮䓬类药物也与 OUD(HR=1.14,95%CI=1.12-1.17)、非致命(HR=1.20,95%CI=1.10-1.30)和致命过量(HR=1.86,95%CI=1.61-2.16)的风险增加相关。
在马萨诸塞州接受初始阿片类药物处方的阿片类药物初治个体中,OUD 的发病风险似乎在 2011 年至 2014 年间有所下降,而过量的发生率基本保持不变。较长的治疗时间和同时使用苯二氮䓬类药物与阿片类药物使用障碍和阿片类药物过量的风险增加相关。